Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma

doi:10.4251/wjgo.v16.i6.2350

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (369)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

HTML

212

Figures (1-4)

Tables (1-1)

Sum=313

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=42

Jun 15, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2350-2361
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2350

Full Size Figure Download Figure

Figure 3 Abnormal angiopoietin-2 expression during hepatocarcinogenesis[37-39,43]. Neovascularization is a fundamental process involved in a variety of pathological processes that sustain the progression of hepatocellular carcinoma. angiopoietin-2 (Ang-2) is a key driver of tumour angiogenesis, and abnormal Ang-2 during hepatocarcinogenesis in rats is closely related to hepatic hypoxia. Ang-2 could be used as an early index to monitor the malignant transformation of hepatocytes. EMT: Epithelial-mesenchymal transition; HRE: Hypoxia-responsive element; VEGF: Vascular endothelial growth factor; HCC: Hepatocellular carcinoma.

Citation: Yao M, Fang RF, Xie Q, Xu M, Sai WL, Yao DF. Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2350-2361
URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2350.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2350